The Health Sciences Institute is intended to provide cutting-edge health information.
Nothing on this site should be interpreted as personal medical advice. Always consult with your doctor before changing anything related to your healthcare.

Addictive amphetamine for six-year-olds gets A-OK from the Feds

Big Pharma is turning our kindergartners into lab rats — and our government is helping them get away with it!

Right now, a frightening new ADHD med called Dyanavel XR is speeding toward your pharmacy and pediatrician’s office.

It’s a powerful liquid amphetamine that keeps our kids drugged for 13 hours straight — and it’s being targeted at children as young as six years old!

The FDA and Tris Pharma want us to believe Dyanavel XR is “pediatric friendly.”

But there’s nothing friendly about the way our government rubber-stamped this drug at a record pace, based on some of the most incomplete science I’ve ever seen.

Or how it intends to put millions of kids in harm’s way with a med that can cause heart problems, stunted growth, and even sudden death.

Hyperactive prescribing
Is there anything we needed less than another ADHD drug?

I’ve been warning you for years how ADHD prescriptions are going through the roof. Big Pharma is selling about $10 billion worth of these drugs a year — and that’s about six times more than they were raking in a decade or so ago.

But with the way the FDA is acting, you would have thought there was a national Ritalin shortage!

The agency just gave Dyanavel XR a fast-tracked approval in just five months. And I wouldn’t even give the science behind this drug an F — more like an “I” for incomplete.

The last double-blind trial for Dyanavel XR — the one that really counts, where the patients and researchers don’t know who’s getting the med — involved a whopping 108 kids and the treatment period lasted just seven days!

Can you believe it? One week! It’ll take longer than that to play the World Series!

And I wish I could tell you that our government granted this lightning fast approval because Dyanavel XR turned out to be as safe as mother’s milk.

But trust me — giving an addictive amphetamine to a six-year-old is every bit as dangerous as it sounds.

The Dyanavel XR label is filled with warnings such as:

  • Blood pressure and heart rate increases;
  • Psychotic adverse reactions;
  • Long-term stunting of growth;
  • Abuse and dependence; and
  • Sudden death.

It’ll even carry a black-box warning. This is the same government that’s warning you not to give powerful cold medicines to your kids — and here they are signing off on a med with a side effects list that’s straight out of a horror movie.

After just a five-month review!

So why is our government turning young kids into lab rats, speeding these new and potentially dangerous drugs to market? There’s a gold rush on — and the FDA doesn’t have the guts to stop it.

You see, when Obamacare became law, it allowed the sale of ADHD meds to take off beyond even Big Pharma’s wildest dreams. That’s because every Obamacare plan must include coverage and treatments for “behavioral disorder assessments” like ADHD.

There are billions of insurance company dollars at stake — and the drug companies mean to grab them, even if their patients keep getting younger and younger.

Last year I told you how the Citizens Commission on Human Rights uncovered that babies just a year old and younger were being given ADHD drugs like Ritalin and even depression meds like Prozac and Paxil.

When we get up to preschoolers at the ripe old age of two and three, they’re being drugged by the hundreds of thousands on anti-anxiety meds, antidepressants and antipsychotics.

It’s practically child abuse by prescription.

Listen, we all want our kids to be emotionally healthy, well behaved and to do well in school. And when you’re told that a little one you love has ADHD, it’s natural to want to spring into action.

And that’s why it’s so important to get a second opinion before you agree to these drugs that many kids end up taking for life.

Because they’ll be putting ADHD meds into baby formula next. And it doesn’t look like the Feds are ready to do anything to stop it.

Sources:
“FDA okays once-daily Dyanavel XR for ADHD in children” Caroline Cassels, October 21, 2015, Medscape, medscape.com

“Tris Pharma receives FDA approval of Dyanavel XR (amphetamine) once-daily liquid for ADHD in children” October 20, 2015, drugs.com

 

Are you taking one of these 9 “memory erasing” prescriptions?

You may think your memory loss is just a sign of getting older, but one of these 9 drugs could actually be damaging your brain…

These 9 prescription drugs have now been linked to Alzheimer’s disease diagnoses.

If you’re over the age of 60, and you’re taking even 1 of these 9 drugs, your brain could be at risk.

Click here to learn more.

 

How often do you eat eggs?

Did you know it does THIS to senior brains?

-Emily

Get a free copy of 5 Household Items that Cause Cancer

By texting HSI to 844-539-1128, you are providing your electronic signature expressly consenting to be called and texted (including by prerecorded messages, using an autodialer, and/or automated means) with alerts, stories, reports, and marketing communications from Institute of Health Sciences, LLC. and its authorized representatives at the phone number you provide, including landlines and wireless numbers, even if the phone number is on a corporate, state or national Do Not Call list. You also consent and unconditionally agree to our Privacy Policy and Terms of Use, including the arbitration provision and class action waiver contained therein. Msg&data rates may apply. 15 Msgs/Month. You are not required to agree to this as a condition of making a purchase.

Terms & Conditions

The following Terms and Conditions apply to your use of the website located at hsionline.com (the “website”) and any text messages that you send to or receive from the Institute of Health Sciences, L.L.C. These Terms and Conditions constitute a binding agreement (“Agreement”) between you (“you”) Institute of Health Sciences, L.L.C (“we”, “us”, etc.)  Please read these terms carefully. 

By providing your telephone number to us, texting us a short code listed on the website, or otherwise indicate your agreement to these Terms and Conditions, you are agreeing to the mandatory arbitration provision and class action waiver below. 

ARBITRATION IS MANDATORY AND THE EXCLUSIVE REMEDY FOR ANY AND ALL DISPUTES RELATED TO THIS WEBSITE, THIS AGREEMENT, AND ANY TELEPHONE CALLS, EMAILS, OR TEXT MESSAGES THAT YOU RECEIVE FROM OR ON BEHALF OF US, UNLESS SPECIFIED BELOW OR UNLESS YOU OPT-OUT.

Text Messaging and Telemarketing Terms and Conditions

When you provide your telephone number on this website or send a text message to us with or from a short-code, you agree to receive alerts and communications, and marketing messages including those sent via automated telephone dialing system, text messages, SMS, MMS, and picture messages from Institute of Health Sciences, L.L.C at the phone number you provide on this website or the phone number from which you text the short code, including on landlines and wireless numbers, even if the phone number is on a corporate, state or national Do Not Call list. You also agree to the mandatory arbitration provision and class action waiver below. Your consent is not required to purchase goods or services. Message & data rates may apply.

You may opt-out at any time by texting the word STOP to the telephone number from which you receive the text messages.  Call 1-888-213-0764 to learn more.  By providing your telephone number, you agree to notify us of any changes to your telephone number and update your account us to reflect this change. Your carrier may charge you for text messages and telephone calls that you receive, or may prohibit or restrict certain mobile features, and certain mobile features may be incompatible with your carrier or mobile device. Contact your carrier with questions regarding these issues.

Dispute Resolution by Binding Arbitration and Class Action Waiver

Any dispute relating in any way to telephone calls, emails, or text messages that you receive from or on behalf of Institute of Health Sciences, L.L.C this website, or this Agreement (collectively “Disputes”) shall be submitted to confidential arbitration and shall be governed exclusively by the laws of the State of Maryland, excluding its conflict of law provisions.  For the avoidance of doubt, all claims arising under the Telephone Consumer Protection Act and state telemarketing laws shall be considered “Disputes” that are subject to resolution by binding individual, confidential arbitration.

If a Dispute arises under this Agreement, you agree to first contact us at 1-888-213-0764 or help@hsionline.com. Before formally submitting a Dispute to arbitration, you and we may choose to informally resolve the Dispute.  If any Dispute cannot be resolved informally, you agree that any and all Disputes, including the validity of this arbitration clause and class action waiver, shall be submitted to final and binding arbitration before a single arbitrator of the American Arbitration Association (“AAA”) in a location convenient to you or telephonically. Either you or we may commence the arbitration process by submitting a written demand for arbitration with the AAA, and providing a copy to the other party.  The arbitration will be conducted in accordance with the provisions of the AAA’s Commercial Dispute Resolutions Procedures, Supplementary Procedures for Consumer-Related Disputes, in effect at the time of submission of the demand for arbitration.  Except as may be required by law as determined by the arbitrator, no party or arbitrator may disclose the existence, content or results of any arbitration hereunder without the prior written consent of both parties. Institute of Health Sciences, L.L.C will pay all of the filing costs.  Without limiting the foregoing, YOU EXPRESSLY AGREE TO SUBMIT TO ARBITRATION ALL DISPUTES RELATING TO ANY TEXT MESSAGES OR TELEPHONE CALLS YOU RECEIVE FROM OR ON BEHALF OF US OR ANY ENTITY WITH WHOM WE MAY SHARE YOUR TELEPHONE NUMBER.  Further, we both agree that all entities with whom we share your telephone numbers shall be third party beneficiaries of this Agreement to Arbitrate Disputes, and that those entities have the same rights as Institute of Health Sciences, L.L.C to enforce this arbitration provision.

Notwithstanding the foregoing, the following shall not be subject to arbitration and may be adjudicated only in the state and federal courts of Maryland: (i) any dispute, controversy, or claim relating to or contesting the validity of our or one of our family company’s intellectual property rights and proprietary rights, including without limitation, patents, trademarks, service marks, copyrights, or trade secrets; (ii) an action by us for temporary or preliminary injunctive relief, whether prohibitive or mandatory, or other provisional relief; (iii) any legal action by us against a non-consumer; or (iv) interactions with governmental and regulatory authorities.  You expressly agree to refrain from bringing or joining any claims in any representative or class-wide capacity, including but not limited to bringing or joining any claims in any class action or any class-wide arbitration.

The arbitrator’s award shall be binding and may be entered as a judgment in any court of competent jurisdiction. To the fullest extent permitted by applicable law, no arbitration under this Agreement may be joined to an arbitration involving any other party subject to this Agreement, whether through a class action, private attorney general proceeding, class arbitration proceedings or otherwise.

YOU UNDERSTAND THAT YOU WOULD HAVE HAD A RIGHT TO LITIGATE IN A COURT, TO HAVE A JUDGE OR JURY DECIDE YOUR CASE AND TO BE PARTY TO A CLASS OR REPRESENTATIVE ACTION.  HOWEVER, YOU UNDERSTAND AND AGREE TO HAVE ANY CLAIMS DECIDED INDIVIDUALLY AND ONLY THROUGH ARBITRATION.  You shall have thirty (30) days from the earliest of the date that you visit the website, the date you submit information to us through the website, or the date that you send a text message to us, to opt out of this arbitration agreement, by contacting us by email at help@hsionline.com or by mail Health Sciences Institute, PO Box 913, Frederick, MD 21705-0913. If you do not opt out by the earliest of the date that you visit the website, the date you submit information to us through the website, or the date that you send a text message to us, then you are not eligible to opt out of this arbitration agreement.

Electronic Signatures

All information communicated on the website is considered an electronic communication.  When you communicate with us through or on the website, by text message or telephone, or via other forms of electronic media, such as e-mail, you are communicating with us electronically.  You agree that we may communicate electronically with you and that such communications, as well as notices, disclosures, agreements, and other communications that we provide to you electronically, are equivalent to communications in writing and shall have the same force and effect as if they were in writing and signed by the party sending the communication.

You further acknowledge and agree that by clicking on a button labeled “ORDER NOW”, “SUBMIT”, “I ACCEPT”, “I AGREE”, “YES”, by texting a short code to us in response to a request on this website, or by clicking or similar links or buttons, you are submitting a legally binding electronic signature and are entering into a legally binding contract.  You acknowledge that your electronic submissions constitute your agreement and intent to be bound by this Agreement.  Pursuant to any applicable statutes, regulations, rules, ordinances or other laws, including without limitation the United States Electronic Signatures in Global and National Commerce Act, P.L. 106-229 (the “E-Sign Act”) or other similar statutes, YOU HEREBY AGREE TO THE USE OF ELECTRONIC SIGNATURES, CONTRACTS, ORDERS AND OTHER RECORDS AND TO ELECTRONIC DELIVERY OF NOTICES, POLICIES AND RECORDS OF TRANSACTIONS INITIATED OR COMPLETED THROUGH THE WEBSITE.  Furthermore, you hereby waive any rights or requirements under any statutes, regulations, rules, ordinances or other laws in any jurisdiction which require an original signature, delivery or retention of non-electronic records, or to payments or the granting of credits by other than electronic means You may receive a physical paper copy of this contract by contacting us at help@hsionline.com.

Privacy Policy

Please read our Privacy Policy, which is incorporated herein by reference.  In the event of any conflict between these Terms and Conditions and the Privacy Policy, these Terms shall control.

Contact Us

You may contact us by telephone at 1-888-213-0764 or by email at help@hsionline.com.